Relevant bibliographies by topics / Endometrial cancer

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Endometrial cancer'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Endometrial cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Endometrial cancer"

1

Arai, Y., and M. Nishida. "Differential diagnosis between normal endometrium and endometrial hyperplasia with immunostaining cytology using anti-LeY monoclonal antibody." International Journal of Gynecologic Cancer 13, no. 1 (2003): 42–46. http://dx.doi.org/10.1136/ijgc-00009577-200301000-00008.

Full text
Abstract:
We have previously reported that both endometrial cancer and endometrial hyperplasia stain positively for the anti-LeY monoclonal antibody, whereas normal endometrium does not. Endometrial hyperplasia is a premalignant change associated with the eventual development of endometrial carcinoma. However, it can be difficult to differentiate hyperplasia from normal endometrium in cytology. This study illustrates the use of immunocytochemical cytology using anti-LeY monoclonal antibody to differentiate between endometrial hyperplasia and normal endometrium. Immunostaining using anti-LeY monoclonal a
APA, Harvard, Vancouver, ISO, and other styles
2

Easo, Anu Sarah, Rajeev Anand, and Mini Issac. "Evaluation of apparent diffusion coefficient in endometrial carcinoma compared to normal endometrium: a retrospective study." International Journal of Research in Medical Sciences 9, no. 7 (2021): 2043. http://dx.doi.org/10.18203/2320-6012.ijrms20212356.

Full text
Abstract:
Background: To determine whether diffusion-weighted imaging (DWI) with measurement of apparent diffusion coefficient (ADC) will help in differentiating endometrial cancer from normal endometrium and to determine whether the grades of endometrial cancer will show significant difference in ADC values.Methods: This is a retrospective study done in MOSC medical college hospital Kolencherry. on patients on whom preoperative MRI was done before hysterectomy. Cases from July 2017 to March 2021 were included. Study cases included 40 females with pathologically confirmed endometrial cancer and 30 femal
APA, Harvard, Vancouver, ISO, and other styles
3

Boyarskikh, Ulyana, Andrey Kechin, Evgeniy Khrapov, et al. "Detecting Microsatellite Instability in Endometrial, Colon, and Stomach Cancers Using Targeted NGS." Cancers 15, no. 20 (2023): 5065. http://dx.doi.org/10.3390/cancers15205065.

Full text
Abstract:
Purpose: To develop a method for testing the MSI based on targeted NGS. Methods: Based on the results of previous studies, 81 microsatellite loci with high variability in MSI-H tumors were selected, and a method for calculating the MSI score was developed. Using the MSI score, we defined the MSI status in endometral (162), colon (153), and stomach (190) cancers. Accuracy of the MSI scores was evaluated by comparison with MMR immunohistochemistry for 137 endometrium (63 dMMR and 74 pMMR), 76 colon (29 dMMR and 47 pMMR), and 81 stomach (8 dMMR and 73 pMMR) cancers. Results: Classification of MSS
APA, Harvard, Vancouver, ISO, and other styles
4

Mokhtar, N. M., F. SA Saghir, A. Mohd Dali, I. Mohamed Rose, and A. A. Jamal. "409. Differentially expressed genes in endometroid endometrial carcinoma using microarray: a preliminary report." Reproduction, Fertility and Development 20, no. 9 (2008): 89. http://dx.doi.org/10.1071/srb08abs409.

Full text
Abstract:
Background: Endometrial cancer is the commonest cancer among women in the western countries. It ranks the fourth in gynaecological cancers incidence in Malaysia. Endometriod carcinoma is the commonest subtype of endometrial cancer. The aetiology of this disease is still not fully understood. Previous theories have suggested the disease is caused by the activation of oncogenes and inactivation of the tumour suppressor genes. The aim of this study is to identify expressing genes involved in the endometrial carcinoma compared with the normal endometrium. Materials and Methods: All endometrial tis
APA, Harvard, Vancouver, ISO, and other styles
5

CAPLAKOVA, VERONIKA, EVA BABUSIKOVA, EVA BLAHOVCOVA, TOMAS BALHAREK, MARIA ZELIESKOVA, and JOZEF HATOK. "DNA Methylation Machinery in the Endometrium and Endometrial Cancer." Anticancer Research 36, no. 9 (2016): 4407–20. http://dx.doi.org/10.21873/anticanres.10984.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kodama, J., T. Kusumoto, N. Seki, et al. "Heparanase expression in both normal endometrium and endometrial cancer." International Journal of Gynecologic Cancer 16, no. 3 (2006): 1401–6. http://dx.doi.org/10.1136/ijgc-00009577-200605000-00069.

Full text
Abstract:
The aim of this study was to investigate the relationship between heparanase expression and prognostic factors in endometrial cancer, as well as the relationship between heparanase expression during phases of the normal endometrial cycle. Immunohistochemical analysis of 166 endometrial cancers and 34 normal endometria in various phases of growth was performed. The heparanase expression in the late-proliferative phase of normal endometria was found to be significantly higher than in either the early-proliferative or the secretory phases (P = .012 and P = .044, respectively). Heparanase expressi
APA, Harvard, Vancouver, ISO, and other styles
7

MARUYAMA, A., T. SAITO, Y. HACHITANDA, and N. TSUKAMOTO. "Cancer history and loss of MSH2 and MLH1 protein expression in patients with endometrial hyperplasia." International Journal of Gynecologic Cancer 13, no. 3 (2003): 352–60. http://dx.doi.org/10.1136/ijgc-00009577-200305000-00015.

Full text
Abstract:
In order to evaluate the hereditary background of endometrial hyperplasia patients in relation to protein expression of DNA mismatch repair genes, we evaluated 69 patients with endometrial hyperplasia and 18 patients with normal endometrium having both a personal and family history of cancer (two hereditary nonpolypoid colorectal cancer (HNPCC) patients). We obtained personal and family histories of cancer for all patients. MSH2 and MLH1 protein expression was investigated by immunohistochemical methods. In the endometrial hyperplasia patients, 11 had personal histories and 40 had family histo
APA, Harvard, Vancouver, ISO, and other styles
8

Rawat, Rajani, Soniya Vishwakarma, Shikha Seth, Vaibhav Kanti, and Pragati Mishra. "Clear Cell Carcinoma of Endometrium: A Clinical Review." Journal of SAFOMS 2, no. 1 (2014): 15–19. http://dx.doi.org/10.5005/jp-journals-10032-1026.

Full text
Abstract:
ABSTRACT Clear cell carcinoma of endometrium is a rare (1-6%) but aggressive malignancy with high propensity of early extra-uterine spread. The usual presentation is postmenopausal bleeding and discharge as with other endometrial cancers but it does not have preceding hyperplastic stage, instead it develops from thin atrophic endometrium, therefore impossible to identify by the screening measures like Pap smear and transvaginal sonography. First step for early diagnosis of such unfavorable endometrial cancer should be endometrial biopsy. Histopathological diagnosis is mandatory to confirm the
APA, Harvard, Vancouver, ISO, and other styles
9

Mandic, Aljosa, and Tamara Vujkov. "Endometrial cancer: Diagnostic methods in postmenopausal vaginal bleeding." Archive of Oncology 11, no. 2 (2003): 97–101. http://dx.doi.org/10.2298/aoo0302097m.

Full text
Abstract:
Postmenopausal vaginal bleeding (PMB) is the leading symptom of endometrial cancer. More than 70% of patients with endometrial cancer are postmenopausal. Despite PMB as a leading symptom in diagnosis of endometrial cancer, PMB could be caused by some benign processes in endometrium such as hyperplasia and focal endometrial disease, such as a polyp. The golden standard for histological evaluation of the endometrium is curettage. Transvaginal ultrasound (TVS) and measurement of endometrium thickness is also one of the favored methods in the last decade. Sonographic imaging of the endometrium can
APA, Harvard, Vancouver, ISO, and other styles
10

Boaventura, Camila Silva, José Lucas Scarpinetti Galvão, Giovanna Milanes Bego Soares, et al. "Synchronous gynecologic cancer and the use of imaging for diagnosis." Revista da Associação Médica Brasileira 62, no. 2 (2016): 116–19. http://dx.doi.org/10.1590/1806-9282.62.02.116.

Full text
Abstract:
Summary Endometrial and cervical cancers are the most prevalent gynecologic neoplasms. While endometrial cancer occurs in older women, cervical cancer is more prevalente in young subjects. The most common clinical manifestation in these two gynecological cancers is vaginal bleeding. In the first case, diagnosis is made based on histological and imaging evaluation of the endometrium, while cervical cancers are diagnosed clinically, according to the International Federation of Gynecology and Obstetrics (FIGO). The authors present a case of synchronous gynecological cancer of the endometrium and
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Endometrial cancer"

1

Wang, Yiying, Yue Wang, Jie Li, et al. "Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium." BioMed Central, 2013. http://hdl.handle.net/10150/610184.

Full text
Abstract:
Lynch syndrome (LS), an autosomal dominant inherited cancer susceptibility syndrome, also known as hereditary non-polyposis colon cancer (HNPCC), is caused by a germline mutation in one of several DNA mismatch repair (MMR) genes. LS is the most common presentation of hereditary colorectal cancer (CRC), accounting for about 2-5% of all CRC cases. More recently, it is found that a similar number of endometrial cancers is also due to one of the MMR gene mutations. There has been significant progress in LS-related CRC in terms of molecular pathogenesis, risks, genetic basis, and cancer prevention.
APA, Harvard, Vancouver, ISO, and other styles
2

Cheng, Timothy. "Genetic susceptibility to endometrial cancer." Thesis, University of Oxford, 2015. http://ora.ox.ac.uk/objects/uuid:3a559ae0-156f-48a2-a64e-b03a13c562df.

Full text
Abstract:
Endometrial cancer (EC) is the fourth most common cancer affecting women in the UK. Those with a family history of EC have an increased risk compared with the general population. Highly penetrant germline mutations in mismatch repair (MMR) genes and DNA polymerases account for only a small proportion of the familial aggregation. The aim of this thesis is to investigate the genetic susceptibility to EC in the general population using cases and controls of European ancestry. A GWAS meta-analysis totalling 7,737 EC cases and 37,144 controls yielded five novel EC risk loci of genome-wide significa
APA, Harvard, Vancouver, ISO, and other styles
3

Kho, Pik Fang. "Genetic epidemiology of endometrial cancer." Thesis, Queensland University of Technology, 2021. https://eprints.qut.edu.au/211383/1/Pik%20Fang_Kho_Thesis.pdf.

Full text
Abstract:
Endometrial cancer is the fifth most common cancer diagnosed in women in developed countries. This research used genetics to assess relationships between endometrial cancer and, previously identified and novel, risk factors. This work brings new insights by providing evidence that HDL and LDL cholesterol levels are linked to endometrial cancer risk. Further, I have shown that two gynaecological diseases, which are comorbid with endometrial cancer, also share genetic risk architecture with endometrial cancer. This work also advances the understanding of biological mechanisms of endometrial canc
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Maxine M. "Genetics and Genomics of Endometrial Cancer." Thesis, Harvard University, 2016. http://nrs.harvard.edu/urn-3:HUL.InstRepos:27201719.

Full text
Abstract:
Endometrial cancer (EC) is the most common gynecological cancer among women in the developed world and is hypothesized to arise from excess estrogen exposure from established risk factors like estrogen-only hormone therapy and obesity. EC is divided into the common “estrogen-dependent” endometrioid subtype and the rare “estrogen-independent” non- endometrioid subtype. However, this broad categorization of EC is not sufficient based on evidence for EC heterogeneity. Furthermore, family history and hereditary syndromes also increase risk, suggesting a genetic component. This dissertation examine
APA, Harvard, Vancouver, ISO, and other styles
5

Falck, Eva. "Genomic Alterations in Experimental Endometrial Adenocarcinoma." Licentiate thesis, Högskolan i Skövde, Institutionen för vård och natur, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-7419.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

魏燕萍 and Yin-ping Ngai. "p21-activated kinases in endometrial carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40738528.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wedrén, Sara. "Genetic susceptibility to breast and endometrial cancer /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7140-053-2/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

鄧國全 and Kwok-tsuen Dang. "Methylation status of endometrial cancer related genes." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B31970497.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nickkho-Amiry, Mahshid. "Peroxisome proliferator-activated receptors in endometrial cancer." Thesis, University of Manchester, 2011. https://www.research.manchester.ac.uk/portal/en/theses/peroxisome-proliferatoractivated-receptors-in-endometrial-cancer(2388ac43-ecd4-402f-a9c7-853be4902ec8).html.

Full text
Abstract:
Endometrial cancer is a common gynaecological cancer. Improving outcomes for women with advanced disease remains a challenge and there is also a need to develop preventative strategies in those women at highest risk of developing disease. Peroxisome proliferator-activated receptors (PPARs) comprise of a group of transcription factors belonging to the nuclear hormone receptor subfamily. PPAR sub-types are involved in metabolic homeostasis and have been implicated in malignancy, particularly breast and colo-rectal malignancies both of which are associated with obesity. Endometrial cancer is also
APA, Harvard, Vancouver, ISO, and other styles
10

Dang, Kwok-tsuen. "Methylation status of endometrial cancer related genes." Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25549583.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Endometrial cancer"

1

Surwit, Earl A., and David S. Alberts, eds. Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

T, Creasman William, ed. Endometrial cancer. Saunders, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

A, Surwit Earl, and Alberts David S. 1939-, eds. Endometrial cancer. Kluwer Academic Publishers, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cancer Research Workshop. (5th 1985 Grenoble, France). Endometrial cancers. Edited by Bolla M, Racinet C, and Vrousos C. Karger, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mirza, Mansoor R., ed. Management of Endometrial Cancer. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-64513-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

A, Quinn M., and Walker J, eds. Controversies in endometrial cancer. Baillière Tindall, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mehta, Sumita, and Bindiya Gupta, eds. Recent Advances in Endometrial Cancer. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-5317-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Patni, Ranu, ed. Current Concepts in Endometrial Cancer. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-3108-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

National Cancer Institute (U.S.), ed. Cancer of the uterus: Endometrial cancer : research report. The Institute, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

National Cancer Institute (U.S.), ed. Cancer of the uterus: Endometrial cancer : research report. The Institute, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Endometrial cancer"

1

Voigt, Lynda F., and Noel S. Weiss. "Epidemiology of endometrial cancer." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wain, Gerard, and C. Paul Morrow. "Surgical management of endometrial cancer." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sutton, Gregory P. "Peritoneal cytology in endometrial carcinoma." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Einhorn, Nina. "The role of preoperative radiotherapy in the treatment of carcinoma of the endometrium." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Potish, Roger A. "Radiotherapy in the management of nodal and peritoneal metastases." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Satyaswaroop, P. G., R. J. Zaino, and R. Mortel. "Carcinoma of the endometrium and hormonal receptors." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Thigpen, Tate. "Systemic therapy with single agents for advanced or recurrent endometrial carcinoma." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brenner, Dean E. "Multiagent chemotherapy of endometrial carcinoma." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Welander, Charles E., Charles M. Jones, David S. Alberts, and Sydney E. Salmon. "In vitro sensitivity of human endometrial cancer to cytotoxic and biologic agents." In Endometrial Cancer. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0867-6_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Goodman, Annekathryn, and Barbara Goff. "Endometrial Cancer." In Uterine Cancer. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-044-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Endometrial cancer"

1

Kürkçü, Raziye Aslıhan, Işın Yesim Yesilkaya Baylan, Erkut Attar, Burcu Selçuk, and Tacha Şerif. "AI-Enhanced Endometrial Cancer Diagnosis System." In 2024 9th International Conference on Computer Science and Engineering (UBMK). IEEE, 2024. https://doi.org/10.1109/ubmk63289.2024.10773504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Iqbal, S. A., H. Shukla, V. Jain, S. Giri, R. Sekhon, and S. Rawal. "Synchronous primary ovarian sex cord tumor and endometrial cancer." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685384.

Full text
Abstract:
Synchronous primary tumors of female genital tract are rare with a rate of about 0.7-1.8% of all gynaecological tumours. Most common primary tumours presenting as synchronous lesions are ovary and endometrium. However, sex cord stromal tumors are rare variety of primary ovarian tumor and synchronous with endometrium is even much rarer. These tumors are detected usually in younger, overweight, nulliparous and perimenopausal female. Synchronous primary tumors of endometrium and ovary have a better prognosis than the either of above alone because these are usually low grade and diagnosed at early
APA, Harvard, Vancouver, ISO, and other styles
3

Marcus, D., A. Savage, J. Balog, et al. "P74 Endometrial cancer: can the iKnife diagnose endometrial cancer?" In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.136.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gupta, Shaveta. "Comparison of MRI findings with actual HPE findings in case of carcinoma endometrium." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685340.

Full text
Abstract:
Objectives: The objectives of this study is to investigate the correlation of magnetic resonance imaging (MRI) in predicting the depth of myometrial invasion, cervical involvement and lymph node involvement and actual histopathological findings in the women with endometrial cancer. Methods: This is a reterospective study of the patients of endometrial cancer from Nov 2011 to Jan 2016 who underwent Surgery (Total abdominal Hystrectomy with B/l salpingoophorectomy with peritoneal washings with b/l pelvic lymphadenectomy with or without para aortic lymphadenectomy) at our centre Max Superspeciali
APA, Harvard, Vancouver, ISO, and other styles
5

Barbosa, L., B. Napoleao, M. Ribeiro, et al. "EPV110/#289 Endometrial aspiration for endometrial cancer diagnosis." In IGCS 2021 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-igcs.180.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gonçalves, Heloísa Helena Rengel, Mariana Burity Xavier, Alfredo Carlos Simões Dornellas de Barros, Graziela Couto de Carvalho, and Larissa Scarabucci Venezian. "ASSOCIATION BETWEEN LEVONORGESTRELRELEASING INTRAUTERINE SYSTEM AND BREAST CANCER." In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1005.

Full text
Abstract:
Introduction: The association between the use of hormonal contraception and breast cancer has been debated in the medical community for years. Although older studies have suggested an increase in breast cancer risk with the use of combined oral contraceptive (COC) pills, more recent studies have demonstrated the relative safety of combined contraceptives composed of estrogen and progesterone. Isolated progestagens are usually prescribed to women who have menstrual cycle disturbances; however, literature on the association between the use of isolated progestagens and breast cancer is still cont
APA, Harvard, Vancouver, ISO, and other styles
7

Pitakkarnkul, Supakorn, Saranya Chanpanitkitchot, and Siriwan Tangjitgamol. "Management of inoperable endometrial cancer." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.e24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mondal, Madhurima, Aditya Lahiri, Haswanth Vundavilli, Giuseppe Del Priore, Peter Reeves, and Aniruddha Datta. "Combination Supplements for Endometrial Cancer." In 2023 IEEE 23rd International Conference on Bioinformatics and Bioengineering (BIBE). IEEE, 2023. http://dx.doi.org/10.1109/bibe60311.2023.00045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Palasz, Natalia Anna. "269 Adenomyosis and endometrial cancer." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.878.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ranade, Rohit Raghunath. "Preoperative and intraoperative assesment of myometrial invasion and histological grade in endometrial cancer: Role of MRI and frozen section." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685336.

Full text
Abstract:
Introduction: The role of systematic lymphadenectomy in clinically early stage endometrial cancer is controversial. A number of factors can predict lymph node metastasis including myometrial invasion, tumor grade in endometrial cancers. The purpose of the present study is to evaluate the accuracy of preoperative MRI and intraoperative frozen section in determining the depth of myometrial invasion, cervical involvement, tumor size and lymph nodal status. We also studied the accuracy of preoperative endometrial biopsy and intraoperative frozen section in determining the grade of the tumor. Mater
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Endometrial cancer"

1

Stute, Petra, Susanne Theis, Argy Kolokythas, et al. Systematic review on the influence of progestogens on the endometrium. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.6.0028.

Full text
Abstract:
Review question / Objective: The objective of this systematic review is to summarize published data from randomized controlled trials regarding the influence of a combined menopausal hormone therapy on the endometrium with specific focus on endometrial hyperplasia and endometrial cancer incidence. Eligibility criteria: The following progestagens will be investigated: Norethisterone (acetate) = NET(A), Dienogest = DNG, Dydrogesterone = DYD, Micronized Progesterone = MP, Drospirenone = DRSP, Levonorgestrel = LNG, Cyproterone acetate = CPA, Medroxyprogesterone acetate = MPA, Chlormadinone acetate
APA, Harvard, Vancouver, ISO, and other styles
2

Tinker, Anna V., Neesha C. Dhani, Prafull Ghatage, et al. Immune Checkpoint Inhibitors in Pretreated Metastatic Endometrial Cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0038.

Full text
Abstract:
Review question / Objective: Efficacy and safety of immune checkpoint inhibitors alone or in combination with tyrosine kinase inhibitors in patients with pretreated advanced, persistent, or recurrent metastatic endometrial cancer. Condition being studied: Advanced, persistent, or recurrent metastatic endometrial cancer. Study designs to be included: Non-randomized studies of monotherapy in populations selected for relevant biomarkers such as MMR, microsatellite stability, and PD-L1 expression status and randomized trials of ICI combinations in unselected patients.
APA, Harvard, Vancouver, ISO, and other styles
3

Maxwell, George L. Molecular Biology and Prevention of Endometrial Cancer. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada509742.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Maxwell, George L. Molecular Biology and Prevention of Endometrial Cancer. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada423688.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Maxwell, George L. Molecular Biology and Prevention of Endometrial Cancer. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada460283.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Maxwell, Goerge L. Molecular Biology and Prevention of Endometrial Cancer. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada472123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Maxwell, George L. Molecular Biology and Prevention of Endometrial Cancer. Addendum. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada491629.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Yan, Wenpeng Song, Sicheng Zhou, et al. Increased risk for subsequent primary lung cancer among female hormone-related cancer patients: a meta-analysis based on over four million cases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.7.0044.

Full text
Abstract:
Review question / Objective: To identify the risk of lung cancer in FHRC patients compared to the general population. Condition being studied: The incidence rate of lung cancer in women is obviously increasing over the past decade and previous evidence have indicated the significant relationship between disturbances in hormone levels and the risk of lung cancer. Therefore, we hypothesized female hormone-related cancer (FHRC), including the breast, endometrial, cervix, and ovary cancer, patients may experience a higher risk of developing subsequent lung cancer.
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Jiaxi, Yuanyuan Peng, Hejia Guo, and Cuiping Li. PAI-1 polymorphisms have significant associations with cancer risk, especially endometrial and colorectal cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.6.0026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lin, Yibin, Qiaoming Lin, Qi Guan, Danru Chen, and Benhua Xu. Immune Cell Prognostic Significance in Endometrial Cancer: A Comprehensive Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.9.0006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Endometrial cancer' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography